Arrhythmias & electrophysiologyCohort study

Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry

Eur Heart JPublished

  • Registry-based observational cohort study
  • international
  • collaborative

Authors' conclusion

Calmodulinopathy has pleiotropic presentations, from channelopathy to syndromic forms. Clinical severity ranges from the early onset of life-threatening arrhythmias to the absence of symptoms, and the percentage of milder and familial forms is increasing.

Study context

Population
CALM-positive patients (mutations in CALM1–3): index cases and family members97 index cases · 43 family members
Participants
140 patients
Exposure
Current International Calmodulinopathy Registry (ICalmR) cohort vs original 2019 cohort
  • ICalmRn = 140

Main finding

As reported in the abstract

Arrhythmic/cardiac events and sudden death
GroupAll cardiac eventsSudden death
Original 201985%27%
  • ICalmR vs Original 2019: P = 0.001 — all cardiac events: 61% vs. 85%
  • ICalmR vs Original 2019: P = 0.008 — sudden death: 9% vs. 27%

Observational data: associations, not effects.

Further findings

OutcomeICalmROriginal 2019P value
All cardiac events, vs original 2019 cohort61%Not reported in the abstractP = 0.001
Sudden death, vs original 2019 cohort9%Not reported in the abstractP = 0.008
  • All cardiac events, vs original 2019 cohort: 2019 85%
  • Sudden death, vs original 2019 cohort: 2019 27%

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry. Eur Heart J. Published 2 August 2023. doi:10.1093/eurheartj/ehad418

Summarised from the published abstract; every number is checked against it